Pharming Group N.V. PHAR

$ 9.1 1.79%

Annual report 2023
added 12-21-2024

Pharming Group N.V. Balance Sheet 2011-2024 | PHAR

Annual Balance Sheet Pharming Group N.V.

	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-	-43.5 M	-	-7.38 M	22.6 M	35.5 M	-15.8 M	-32.6 M	-15 M	-2.42 M	-344 K
Long Term Debt	-	-	-	122 M	-	37.3 M	58.7 M	40.4 M	11.8 M	-	-	-	-
Long Term Debt Current	-	-	-	1.6 M	1.95 M	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	21.6 M	70.2 M	88.9 M	47.9 M	20.4 M	11 M	13.5 M	15.5 M	17.7 M
Total Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	-	-	191 M	124 M	153 M	147 M	99.3 M	33.8 M	25.9 M	26.4 M	24.5 M	25.9 M
Deferred Revenue	-	-	-	20.5 M	-	800 K	804 K	943 K	2.21 M	2.2 M	2.2 M	1.94 M	-
Retained Earnings	-	-	-	-257 M	-298 M	-334 M	-356 M	-279 M	-264 M	-257 M	-268 M	-264 M	-258 M
Total Assets	-	-	-	-	-	215 M	166 M	127 M	57.7 M	55.7 M	31.4 M	16.8 M	24.7 M
Cash and Cash Equivalents	-	-	-	167 M	66.3 M	80.3 M	-	-	-	-	-	-	-
Book Value	-	-	-	-191 M	-124 M	61.8 M	18.8 M	27.5 M	23.8 M	29.8 M	5.01 M	-7.65 M	-1.19 M
Total Shareholders Equity	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in EUR currency

Quarterly Balance Sheet Pharming Group N.V.

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	-	-	-	-	-	-	-	-	6.7 M	-	-	-	4.36 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	129 M	-	-	-	21.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-	-	-	-	-	-	-	-	-258 M	-	-	-	-298 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	-	-	-	-	-	-	-	-	341 M	-	-	-	228 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	-	-	-	-	-	-	-	-	167 M	-	-	-	66.3 M	-	-	-	80.3 M	-	-	-	58.7 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	-	-	-	-	-	-	-	-	341 M	-	-	-	228 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	-	-	-	-	-	-	-	-	149 M	-	-	-	105 M	-	-	-	61.8 M	-	-	-	16.1 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in EUR currency